Skip to main content

Market Overview

20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

AC Immune, Inc. (NASDAQ:ACIU) shares rose 88.45% to $13.55 during Thursday's pre-market session.

Nabriva Therapeutics, Inc. (NASDAQ:NBRV) stock increased by 62.40% to $1.08.

Lannett, Inc. (NYSE:LCI) shares increased by 28.27% to $6.60.

Tiziana Life Sciences, Inc. (NASDAQ:TLSA) shares rose 10.42% to $9.53.

Intec Pharma, Inc. (NASDAQ:NTEC) shares moved upwards by 9.39% to $0.34.

Veru, Inc. (NASDAQ:VERU) shares increased by 7.66% to $3.37. The most recent rating by Oppenheimer, on May 14, is at Outperform, with a price target of $9.

Adamis Pharmaceuticals, Inc. (NASDAQ:ADMP) shares increased by 6.47% to $0.70. The most recent rating by Maxim Group, on May 13, is at Buy, with a price target of $2.

NextCure, Inc. (NASDAQ:NXTC) shares moved upwards by 5.10% to $9.47. The most recent rating by Benchmark, on Jul 16, is at Buy, with a price target of $17.

Enzo Biochem, Inc. (NYSE:ENZ) shares rose 4.39% to $2.61.

BioNTech, Inc. (NASDAQ:BNTX) stock increased by 3.97% to $81.10. The most recent rating by Canaccord Genuity, on Jul 13, is at Buy, with a price target of $75.

 

Losers

Tricida, Inc. (NASDAQ:TCDA) stock decreased by 33.63% to $17.39 during Thursday's pre-market session.

INmune Bio, Inc. (NASDAQ:INMB) stock fell 16.48% to $10.90. The most recent rating by HC Wainwright & Co., on Jul 15, is at Buy, with a price target of $20.

Lianluo Smart, Inc. (NASDAQ:LLIT) stock decreased by 12.40% to $0.52.

Aptose Biosciences, Inc. (NASDAQ:APTO) stock fell 11.83% to $5.52.

VIVUS, Inc. (NASDAQ:VVUS) stock decreased by 9.31% to $0.47.

Genetic Technologies, Inc. (NASDAQ:GENE) stock decreased by 8.29% to $5.20.

Immutep, Inc. (NASDAQ:IMMP) stock declined 8.22% to $1.34.

Ocugen, Inc. (NASDAQ:OCGN) shares declined 6.63% to $0.20. The most recent rating by Chardan Capital, on Jun 3, is at Buy, with a price target of $1.

Equillium, Inc. (NASDAQ:EQ) shares declined 6.24% to $16.25. The most recent rating by HC Wainwright & Co., on Jul 14, is at Buy, with a price target of $24.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares declined 5.49% to $3.10. The most recent rating by JP Morgan, on May 27, is at Overweight, with a price target of $6.

 

Related Articles (NBRV + ACIU)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com